Thu, 14 Nov 2019

Contract Research Organization (CRO) Market

The report offers a measurable and verifiable method to analyze market concentration, new entrants and technological advancement and market trends in the future. Further to get in-depth view of Market competitive landscape and Size, Global Contract Research Organization (CRO) Market study is segmented by Application/ end users [For a full, detailed list, view our report]. Geographically, this report study is segmented into several key Regions such as Americas, APAC, EMEA & The report, Contract Research Organization (CRO) Market in sector 2018-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

Contract Research Organization (CRO) Market to 2025 – Global Analysis and Forecasts by Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services); End User (Pharmaceutical & Biotechnology Companies and Medical Device companies) and Geography

According to a new market research study titled 'Contract Research Organization (CRO) Market to 2025 – Global Analysis and Forecasts by Product, Type and Application, the global Contract Research Organization (CRO) market The global contract research organization (CRO) market is expected to reach US$ 68,198.3 Mn in 2025 from US$ 35,818.9 in 2017. The market is estimated to grow with a CAGR of 8.6% from 2018-2025.

Request Sample Copy is Available at:

Key Benefits-

  • To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Contract Research Organization (CRO) Market
  • To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)

Global Contract Research Organization (CRO) Market: Competitive Players:

  • Laboratory Corporation of America Holdings
  • PAREXEL International Corporation
  • Syneos Health
  • PRA Health Sciences
  • Charles River
  • ICON plc
  • Pharmaceutical Product Development, LLC
  • WuXi AppTec
  • Medpace

Research and development (R&D) is an essential and crucial part of the company's business. Pharmaceutical and biotech companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. Research and development expenditures relate to the processes of discovering, testing and developing new products, upfront payments and milestones, improving existing products, as well as demonstrating product efficacy and regulatory compliance prior to launch. According to the International Federation of Pharmaceutical Manufacturers & Associations, the R&D expenditures in 2014 by the pharmaceuticals and biotechnology industry grew by approximately 8.7% than that of the expenditures in 2013. Moreover, in United States, investments for R&D by pharmaceutical companies had grown consistently over the last 15 years. The intensity for R&D by the companies in Japan accounted for about 13.3%, in US it accounted approximately 17% and in the European Union it was registered to be approximately 13% in the year 2014.

Clinical trials are the crucial and significant step in discovering whether the medical strategy, treatment, or device is safe and effective for human use. The clinical studies help in understanding and determining the best medical approaches for certain therapeutic area. Clinical trials are conducted primarily to collect data regarding the safety and efficacy of new drug and device development. Before the approval of drug molecules and the medical devices by the regulatory authorities, series of clinical studies are conducted. Increasing prevalence of various communicable and non-communicable diseases are increasing the demand for the development of new drugs or medical devices for the treatment. This is in turn expected to increase the demand of the clinical trial activities for various therapeutic areas. As per the US National Library of Medicine presently approximately, 280, 801 clinical studies have been listed with locations of 50 states and 204 countries in till 2018. The number of registered studies by August 2018, is shows the rise in the number of the registration for the clinical trials.

What our report offers:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Contract Research Organization (CRO) Market
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Contract Research Organization (CRO) Market, thereby allowing players to develop effective long term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Want Full Report? Inquire Here:

About UsThe Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Information:

The Insight partners, Phone: +1-646-491-9876 Email:


More Miami News

Access More

Sign up for Miami News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!